Trinity Stock Analysis


USD 1.41  0.03  2.17%   

The current rise in Trinity Bio ADR short term price appreciation created some momentum for investors as it was traded today as low as 1.36 and as high as 1.44 per share. The company management teams have successfully maneuvered the company at convenient times to take advantage of all market conditions in July. The stock standard deviation of daily returns for 90 days investing horizon is currently 2.93. The current volatility is consistent with the ongoing market swings in July 2022 as well as with Trinity Bio ADR unsystematic, company-specific events.
Additionally, take a look at World Market Map.
The Trinity Bio stock analysis report makes it easy to digest most publicly released information about Trinity Bio and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Trinity Stock analysis module also helps to analyze the Trinity Bio price relationship with some important fundamental indicators such as market cap and management efficiency.

Trinity Stock Analysis Notes

About 43.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.38. Trinity Bio ADR last dividend was issued on the 5th of June 2015. The entity had 1:4 split on the 2nd of June 2005. Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market in the Americas, Africa, Asia, and Europe. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland. Trinity Bio operates under Pharmaceuticals And Biosciences classification in the United States and is traded on NASDAQ Exchange. It employs 477 people. To find out more about Trinity Bio ADR contact the company at 353 1 276 9800 or learn more at

Trinity Bio ADR Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Trinity Bio's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Trinity Bio ADR or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Trinity Bio ADR may become a speculative penny stock
The company reported the previous year's revenue of 86.15 M. Net Loss for the year was (12.95 M) with profit before overhead, payroll, taxes, and interest of 38.08 M.

Trinity Bio ADR Upcoming and Recent Events

Earnings reports are used by Trinity Bio to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Trinity Bio previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report14th of March 2017
Next Financial Report18th of April 2017
Next Fiscal Quarter End31st of December 2016
Next Fiscal Year End14th of March 2017
Last Quarter Report30th of September 2016
Last Financial Announcement31st of December 2015

Trinity Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Trinity Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Trinity Bio ADR backward and forwards among themselves. Trinity Bio's institutional investor refers to the entity that pools money to purchase Trinity Bio's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Hunter Associates Investment Management LlcCommon Shares1.8 M2.2 M
Renaissance Technologies LlcCommon Shares1.5 M1.8 M
Acadian Asset Management LlcCommon Shares760.2 K931 K
Whitefort Capital Management LpCommon Shares409.5 K502 K
Envestnet Asset Management IncCommon Shares98.1 K120 K
Lpl Financial LlcCommon Shares48.8 K60 K
Simplex Trading LlcCall Options33.3 K40 K
Wealthsource Partners LlcCommon Shares30.2 K37 K
Concourse Financial Group Securities IncPut Options0.00.0
Note, although Trinity Bio's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Trinity Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 29.47 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Trinity Bio's market, we take the total number of its shares issued and multiply it by Trinity Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Trinity Profitablity

Trinity Bio's profitability indicators refer to fundamental financial ratios that showcase Trinity Bio's ability to generate income relative to its revenue or operating costs. If, let's say, Trinity Bio is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Trinity Bio's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Trinity Bio's profitability requires more research than a typical breakdown of Trinity Bio's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (15.1) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 6.96 %, which suggests for every 100 dollars of sales, it generated a net operating income of 0.07.

Management Efficiency

The entity has return on total asset (ROA) of 3.1 % which means that it generated profit of $3.1 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of (190.56) %, meaning that it created substantial loss on money invested by shareholders. Trinity Bio management efficiency ratios could be used to measure how well trinity bio adr manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 14th of August 2022, Trinity Bio has the Coefficient Of Variation of 861.3, semi deviation of 2.87, and Risk Adjusted Performance of 0.1511. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Trinity Bio ADR, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to collect and analyze data for nineteen technical drivers for Trinity Bio ADR, which can be compared to its competition. Please validate Trinity Bio ADR jensen alpha, as well as the relationship between the potential upside and skewness to decide if Trinity Bio is priced more or less accurately, providing market reflects its prevalent price of 1.41 per share. Please also confirm Trinity Bio ADR total risk alpha, which is currently at 0.1622 to double-check the company can sustain itself at a future point.

Trinity Bio ADR Price Movement Analysis

The output start index for this execution was thirty-one with a total number of output elements of thirty. The Kaufman Adaptive Moving Average allows the user to define Trinity Bio ADR range across which they want the smoothing.

Trinity Bio Predictive Daily Indicators

Trinity Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Trinity Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Trinity Bio Forecast Models

Trinity Bio time-series forecasting models is one of many Trinity Bio's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Trinity Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Trinity Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Trinity Bio stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Trinity shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Trinity Bio. By using and applying Trinity Stock analysis, traders can create a robust methodology for identifying Trinity entry and exit points for their positions.
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market in the Americas, Africa, Asia, and Europe. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland. Trinity Bio operates under Pharmaceuticals And Biosciences classification in the United States and is traded on NASDAQ Exchange. It employs 477 people.

Current Trinity Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Trinity analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Trinity analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
Trinity Bio ADR current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Trinity analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Trinity stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Trinity Bio ADR, talking to its executives and customers, or listening to Trinity conference calls.
Trinity Analyst Advice Details

Trinity Stock Analysis Indicators

Trinity Bio ADR stock analysis indicators help investors evaluate how Trinity Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Trinity Bio shares will generate the highest return on investment. By understating and applying Trinity Bio stock analysis, traders can identify Trinity Bio position entry and exit signals to maximize returns.
Quick Ratio1.80
Fifty Two Week Low0.8600
Revenue Growth-26.60%
Shares Short Prior Month478.66k
Average Daily Volume Last 10 Day37.95k
Average Daily Volume In Three Month54.65k
Shares Percent Shares Out1.19%
Gross Margins39.97%
Forward Price Earnings7.05
Float Shares19.16M
Fifty Two Week High3.0500
Enterprise Value To Ebitda14.14
Fifty Day Average1.3400
Two Hundred Day Average1.3540
Enterprise Value To Revenue1.31
Additionally, take a look at World Market Map. Note that the Trinity Bio ADR information on this page should be used as a complementary analysis to other Trinity Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for Trinity Stock analysis

When running Trinity Bio ADR price analysis, check to measure Trinity Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trinity Bio is operating at the current time. Most of Trinity Bio's value examination focuses on studying past and present price action to predict the probability of Trinity Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Trinity Bio's price. Additionally, you may evaluate how the addition of Trinity Bio to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Equity Valuation
Check real value of public entities based on technical and fundamental data
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Is Trinity Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Trinity Bio. If investors know Trinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Trinity Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
53.7 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Trinity Bio ADR is measured differently than its book value, which is the value of Trinity that is recorded on the company's balance sheet. Investors also form their own opinion of Trinity Bio's value that differs from its market value or its book value, called intrinsic value, which is Trinity Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Trinity Bio's market value can be influenced by many factors that don't directly affect Trinity Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Trinity Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Trinity Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Trinity Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.